About Altimmune Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://altimmune.com/
Frequently Asked Questions
What is the 52-week range for ALT?
The 52-week high is $6.44 and the 52-week low is $2.56.
What is the P/E ratio for ALT?
The P/E ratio data is currently unavailable.
What is the dividend yield for ALT?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -31.41%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -214860.98%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 1.67.
Analyst Recommendation Trends
Wall Street analyst consensus for ALT over the last few months:
Latest ALT News
Altimmune Details Pemvidutide’s Path Toward a Liver-Disease Franchise
Altimmune (NASDAQ:ALT) executives outlined the company’s strategy to build a liver-disease franchise around pemvidutide, a dual glucagon/GLP-1 agonist being developed for metabolic dysfunction-associated steatohepatitis, or MASH, alcohol use disorder, or AUD, and alcohol-related liver disease, or AL
Altimmune to Participate in Stifel Cardiometabolic Forum
GAITHERSBURG, Md., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that management will participate in a fireside chat at the Stifel 2026 Virtual Cardiometabolic Forum on Wednesday, September 30, 2026, at 10:30 a.m. ET. A webcast of the fireside chat will be available via the Events section of the Altimmune website. About Altimmune Altimmune is a late clinic
Evercore ISI Group Maintains Outperform on Altimmune, Lowers Price Target to $17
Evercore ISI Group analyst Liisa Bayko maintains Altimmune (NASDAQ:ALT) with a Outperform and lowers the price target from $18 to $17.
VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 ‘Multi-Blockbusters’
Novo targets over $23 billion in risk-adjusted pipeline sales by 2035, excluding any contribution from future acquisitions.
Why Is Altimmune (ALT) Up 14.2% Since Last Earnings Report?
Altimmune (ALT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Altimmune’s (ALT) Three Liver Trials Move Forward At Once
On August 12, Altimmune (NASDAQ:ALT) reported second quarter results that read less like a routine earnings update and more like a status check on three separate diseases at the same time. The clinical-stage biopharmaceutical company disclosed a newly launched global Phase 3 trial in MASH, positive Phase 2 data in alcohol use disorder, and completed […]
Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference
GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing pemvidutide to address serious liver diseases, today announced that management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Thursday, September 10, 2026, at 9:30 a.m. ET. A webcast of the fireside chat will be available via the Events section of the Altimmune website. About Altimmune Altimmune is a late clin
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-16 | Richardson Linda M | -24,000 | - | - |
| 2026-09-16 | Richardson Linda M | -6,826 | $3.24 | $22,116 |
| 2026-09-16 | Richardson Linda M | +24,000 | - | - |
| 2026-08-13 | Durso Jerome Benedict | +15,000 | $2.95 | $44,250 |
| 2026-07-31 | Roberts M Scot | +875 | $2.414 | $2,112 |
| 2026-07-31 | WEAVER GREGORY L | +1,753 | $2.414 | $4,232 |
| 2026-05-01 | Pisano Wayne | +48,800 | - | - |
| 2026-05-01 | Hodges Philip | +48,800 | - | - |
| 2026-05-01 | Jorkasky Diane | +48,800 | - | - |
| 2026-05-01 | Lawver Teri L | +48,800 | - | - |
| 2026-05-01 | Schafer Klaus | +48,800 | - | - |
| 2026-05-01 | Sohn Catherine A. | +48,800 | - | - |
| 2026-05-01 | GILL JOHN | +48,800 | - | - |
| 2026-05-01 | SAYARE MITCHEL | +48,800 | - | - |
| 2026-04-06 | GILL JOHN | +9,200 | $3.4076 | $31,350 |
| 2026-04-01 | Durso Jerome Benedict | +15,000 | $3.14 | $47,100 |
| 2026-04-01 | WEAVER GREGORY L | +10,000 | $3.1499 | $31,499 |
| 2026-03-06 | Durso Jerome Benedict | +20,000 | $3.5395 | $70,790 |
| 2026-03-06 | WEAVER GREGORY L | +5,000 | $3.54 | $17,700 |
| 2026-02-26 | WEAVER GREGORY L | +111,000 | - | - |
| 2026-02-26 | WEAVER GREGORY L | +259,000 | - | - |
| 2026-02-26 | Roberts M Scot | +95,430 | - | - |
| 2026-02-26 | Roberts M Scot | +222,670 | - | - |
| 2026-02-02 | Roberts M Scot | -7,775 | - | - |
| 2026-02-02 | Roberts M Scot | -2,329 | $5.55 | $12,926 |
| 2026-02-02 | Roberts M Scot | +7,775 | - | - |
| 2026-01-31 | Roberts M Scot | +5,567 | $3.07 | $17,091 |
| 2026-01-31 | Jordt Raymond M | +4,571 | $3.07 | $14,033 |
| 2026-01-31 | Garg Vipin K | +6,926 | $3.07 | $21,263 |
| 2026-01-30 | Roberts M Scot | -9,275 | - | - |
| 2026-01-30 | Roberts M Scot | -2,859 | $5.6 | $16,010 |
| 2026-01-30 | Roberts M Scot | +9,275 | - | - |
| 2026-01-30 | Garg Vipin K | -26,775 | - | - |
| 2026-01-30 | Garg Vipin K | -11,632 | $5.6 | $65,139 |
| 2026-01-30 | Garg Vipin K | +26,775 | - | - |
| 2026-01-27 | Jordt Raymond M | -15,850 | - | - |
| 2026-01-27 | Jordt Raymond M | -4,229 | $6.18 | $26,135 |
| 2026-01-27 | Jordt Raymond M | +15,850 | - | - |
| 2026-01-27 | Roberts M Scot | -15,850 | - | - |
| 2026-01-27 | Roberts M Scot | -4,748 | $6.18 | $29,343 |
| 2026-01-27 | Roberts M Scot | +15,850 | - | - |
| 2026-01-27 | Garg Vipin K | -41,200 | - | - |
| 2026-01-27 | Garg Vipin K | -17,898 | $6.18 | $110,610 |
| 2026-01-27 | Garg Vipin K | +41,200 | - | - |
| 2026-01-25 | Jordt Raymond M | -14,600 | - | - |
| 2026-01-25 | Jordt Raymond M | -3,855 | $5.5 | $21,203 |
| 2026-01-25 | Jordt Raymond M | +14,600 | - | - |
| 2026-01-25 | Roberts M Scot | -14,600 | - | - |
| 2026-01-25 | Roberts M Scot | -4,373 | $5.5 | $24,052 |
| 2026-01-25 | Roberts M Scot | +14,600 | - | - |
| 2026-01-25 | Garg Vipin K | -42,050 | - | - |
| 2026-01-25 | Garg Vipin K | -17,984 | $5.5 | $98,912 |
| 2026-01-25 | Garg Vipin K | +42,050 | - | - |
| 2026-01-08 | Pisano Wayne | +5,000 | $4.082 | $20,410 |
| 2026-01-05 | Sohn Catherine A. | +500 | $4.2351 | $2,118 |
| 2026-01-01 | Jordt Raymond M | -9,375 | - | - |
| 2026-01-01 | Jordt Raymond M | -2,475 | $3.61 | $8,935 |
| 2026-01-01 | Jordt Raymond M | +9,375 | - | - |
| 2025-12-29 | Jorkasky Diane | +527 | $3.8 | $2,003 |
| 2025-12-23 | GILL JOHN | +12,500 | $4.1 | $51,250 |
| 2025-12-22 | Durso Jerome Benedict | +12,500 | $4.1255 | $51,569 |
| 2025-12-01 | Durso Jerome Benedict | +633,700 | - | - |
| 2025-12-01 | Durso Jerome Benedict | +1,824,400 | - | - |
| 2025-11-11 | WEAVER GREGORY L | -18,750 | - | - |
| 2025-11-11 | WEAVER GREGORY L | -5,672 | $4.28 | $24,276 |
| 2025-11-11 | WEAVER GREGORY L | +18,750 | - | - |